Employee activism is on the rise, impacting businesses of all sizes and touching on employment and labor law risks that are not always immediately evident. This webinar will explore the key issues driving this trend and the various legal concerns raised as well as provide practical strategies for managing its potential impact, including reputational damage, legal challenges, and internal conflict.
Join us to learn how to navigate the complexities of employee activism and mitigate potential risks to your organization by:
- Understanding the drivers of employee activism
- Identifying potential risks for your organization
- Learning legal considerations and best practices
- Developing effective communication and response strategies
Event Recording
Click here to access the PPT presentation.
Relevant Articles
- https://www.foley.com/insights/publications/2025/01/president-trump-ends-affirmative-action-requirements-for-federal-contractors/
- https://www.foley.com/insights/publications/2025/01/president-trumps-rescission-executive-order/
- https://www.foley.com/insights/publications/2025/01/immigration-law-enforcement-i-9-inspections-site-visits/
- https://www.foley.com/insights/publications/2025/01/president-trumps-inauguration-day-immigration-executive-orders/
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…